Wistron is a world-renowned comprehensive technical service provider in the information and communication technology (ICT) industry and boasts abundant experience in design and manufacturing in the ICT field. Recently, Wistron began a cross-industry integration that leverages its strengths in ICT integration to enter the medical industry chain. It currently owns GMP manufacturing plants in Hsinchu, Taiwan, and Chongqing, China that produces medical equipment while also helping clients in Taiwan and abroad to develop related technology, improve product function, and optimize costs. It is currently collaborating with multiple well-known medical equipment companies in Taiwan where the client proposes the idea, proof of concept, or prototype, and Wistron takes over the R&D, manufacturing, and commercialization. Wistron provides solutions for the issues the clients face in R&D, production, and cost structuring.
At the upcoming Taiwan Healthcare+ Expo this year, Wistron will provide a new focus of attention on its concrete progress in product development. Aside from introducing two innovative medical equipment products - the wearable robotic exoskeleton and the artificial intelligence assistance system for hemodialysis - Wistron will also invite three major medical equipment ODM clients in a joint exhibit as an alliance. The exhibit is expected to be the focal point at the Expo, where Wistron will seek trade partners in the Asia-Pacific or buyers to discuss product cooperation and marketing solutions.
Wearable Robotic Exoskeleton Combines AI and Bioinspired Technologies to Help Persons with Mobility Impairment Walk Again
As the world population continues to age at an accelerated speed, the number of people with lower limb motor impairment is also increasing. Robotic exoskeletons are currently seen as a solution to help patients regain their mobility. However, the market is still in its infant stage, and the high development costs and price tags are keeping the products from becoming widespread. Seeing the market need and the opportunity it presents, Wistron has collaborated with several powered exoskeleton companies and made strategic investments in recent years. The list of collaborators and companies it funds include Free Bionics, founded by a team from ITRI, and Canadian companies Bionik and B-Temia.
The robot slated for a public demonstration at the 2018 Taiwan Healthcare Expo is the commercialized result of the joint development effort by Wistron and B-Temia, the Canadian startup funded by Wistron. The expo organizers took the time to ask Wistron to compare the features of this wearable robotic exoskeleton with competing products currently on the European and US markets, as well as its advantages.
Donald Hwang, CTO of Wistron and CEO of Wistron Medical, says that the robotic exoskeleton jointly developed with B-Temia of Canada has been reduced to 6.8 kg and works by using biosensors to detect the hip and knee joint movements of the user, and with its patented DermoskeletonTM technology, providing a precise power output to assist the user in completing their movement. The DermoskeletonTM technology uses AI analysis and computation to determine the activation of the servo motor and decelerator. The user's gait is completely matched to ensure safety. Overall, the product boasts advantages over other products for its easier operation, lighter weight, and lower overall cost.
"Combining Technology and Healthcare to Make Human Life Better" is the company vision, emphasized Hwang. Developing a new robotic exoskeleton not only helps patients in rehabilitation, but will provide an assistive technology solution for the pressure facing long-term care as the aging population continues to grow. Wistron is developing its medical device business with a service mentality, hoping that one day these expensive medical devices can be provided at a reasonable price that is affordable for every user.
In March of this year, Wistron and NTUH have begun their collaboration with clinical testing of the lower limb robotic exoskeleton. The hope is to help patients whose lower limbs are not yet completely paralyzed walk again so they can regain control over their own lives and improve their quality of life. In the future, the product can be applied to patients with mobility impairment due to diseases such as multiple sclerosis, Parkinson's Disease, arthritis, and stroke. This product will make its debut at the Taiwan Healthcare+ Expo this year and is expected to draw the attention of the audience and buyers alike, giving them a glimpse of the future of medical technology.
Wistron Corporation is a Technology Service Provider supplying ICT (information and communication technology) products, services, and systems to global customers. Wistron focuses on ICT (information and communication technology) products, including notebook PCs, desktop PCs, servers, storage, LCD TVs, handheld devices, and devices and equipment for medical applications.